Production (Stage)
Hemostemix Inc.
HEM.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.38M | 1.12M | 1.21M | 1.18M | 1.43M |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.39M | 1.05M | 1.13M | 1.15M | 1.73M |
| Operating Income | -1.39M | -1.05M | -1.13M | -1.15M | -1.73M |
| Income Before Tax | -1.90M | -1.47M | -1.43M | -1.26M | -1.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.90 | -1.47 | -1.43 | -1.26 | -1.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.90M | -1.47M | -1.43M | -1.26M | -1.85M |
| EBIT | -1.39M | -1.05M | -1.13M | -1.15M | -1.73M |
| EBITDA | -1.39M | -1.05M | -1.13M | -1.15M | -1.72M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 380.24M | 360.09M | 357.48M | 351.56M | 340.24M |
| Average Diluted Shares Outstanding | 380.24M | 360.09M | 357.48M | 351.56M | 340.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |